Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Grant or award Director acquired 1,000 shares (grant or award)
  2. 4 Grant or award Sr VP/Chief Commercial Officer acquired 6,000 shares (grant or award)
  3. 4 Grant or award Director acquired 1,000 shares (grant or award)
  4. 4 Grant or award Director acquired 1,000 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Shares withheld for taxes SVP and Chief Development Off. gave up 132,700 shares (to pay taxes)
  7. 4 Option exercise Sr. VP & Corp. Secretary acquired 400 shares (option exercise)
  8. 4 Open-market sale Director sold 6,222 shares at $4.45 ($27,688)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Director sold 51,813 shares at $7.72 ($399,996)
  17. 4 Grant or award Director acquired 1,000 shares (grant or award)
  18. 4 Grant or award SVP and Chief Development Off. acquired 10,000 shares (grant or award)
  19. 4 Grant or award Sr. VP & Corp. Secretary acquired 3,000 shares (grant or award)
  20. 4 Grant or award Director acquired 1,000 shares (grant or award)

Page 22 of 26 · 512 filings